OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
This is a summary curated by AIFuture. Read the complete article at the original source:
Read the full story on OpenAI